Search

everythinglearnresearchcommunity

for

Search:↓

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

B6J mice live longer before 24 months, but B6N mice live longer after; both strains show weight gain, increased food and water intake, and health issues as they age.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Obesity and lifestyle strongly affect heart aging.

AR gene variations don't affect aging markers in men.

Dimeric peptide derivatives could help hair growth and treat hair loss safely.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Banana plant leaves extract may have cancer-fighting and antioxidant properties.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

Silver nanoparticles made from Grewia optiva leaf extract show strong antibacterial, antioxidant, and hair growth benefits.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Male C57BL/6 mice show age-related fluctuations in certain hormones and their ratios in both blood and hair.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Higher pre-pregnancy BMI is linked to more stress in mothers and more behavioral problems in two-year-old children.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Epigenetic changes in skin cells contribute to aging, but targeting these changes may offer new antiaging treatments.

3D cultivation and prenatal stem cell exosomes improve stem cell treatment results, especially for hair loss and age-related issues.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Secukinumab can cause hair loss, which may improve after stopping the medication.

No cure exists for alopecia areata; treatments aim to manage symptoms.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.